ASCO Annual Meeting
May 30, 2015
A recent study shows that adding docetaxel (Docefrez, Taxotere) chemotherapy to the standard treatment of hormone therapy and radiation therapy helps men with high-risk, localized prostate cancer live longer. Having a high-risk, localized prostate cancer means that the tumor has grown throughout the prostate gland, the tumor has a high grade or Gleason score, and the man has a high prostate-specific antigen (PSA) level. The Gleason score is based on how much the tumor looks like healthy tissue when viewed under a microscope.